封面
市场调查报告书
商品编码
1855873

2025年可说明诊断人工智慧全球市场报告

Explainable Artificial Intelligence For Diagnostics Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,可解释诊断人工智慧市场发展迅速,预计到2024年将达到13.4亿美元,到2025年将达到16.9亿美元,复合年增长率达26.0%。这段时期的成长主要受以下因素驱动:文明病疾病的增加、对疾病早期检测需求的增长、患者对个人化医疗意识的提高、对准确高效诊断解决方案的需求不断增长,以及医学影像和病理数据的日益普及。

预计未来几年,可解释人工智慧诊断市场规模将呈指数级增长,到2029年将达到42.1亿美元,年复合成长率(CAGR)为25.7%。预测期内的成长预计将受到以下因素的驱动:对可解释和可解读人工智慧解决方案的需求不断增长、个人化医疗的需求日益增加、对预测分析的重视程度不断提高、监管机构对人工智慧主导诊断的支持力度不断加大,以及对医疗决策透明度的需求日益增长。预测期内的主要趋势包括:用于透明预测的人工智慧演算法的进步、人工智慧与医学影像和基因组学的融合、云端基础诊断平台的开发、自动化病理评分系统的创新以及用户友好型可解读性仪表板的改进。

可解释诊断人工智慧是将人工智慧应用于医疗保健领域,提供透明且可解释的输出结果,使临床医生和患者能够理解诊断决策的製定过程。其主要目标是透过简化演算法,提高人工智慧主导的医疗评估的信任度、课责和准确性。

可解释诊断人工智慧的主要组成部分包括软体、硬体和服务。软体由程式、指令或资料构成,用于操作电脑并执行特定任务。部署方式包括本地部署和云端基础解决方案。应用领域涵盖医学影像、病理学、基因组学、风险评估、治疗建议等。主要终端使用者包括医院、诊断实验室、研究机构和诊所。

美国在2025年春季突然提高关税,由此引发的贸易摩擦对医疗保健产业造成了严重衝击,尤其对关键医疗设备、诊断试剂和药品的供应造成了严重影响。医院和医疗机构面临进口手术器械、影像设备以及注射器、导管等耗材成本不断上涨的困境。这些成本的增加加剧了医疗预算的紧张,导致一些医疗机构必须推迟设备升级或将成本转嫁给患者。此外,原料和零件的关税也阻碍了必需药品和医疗设备的生产,造成供应链瓶颈。为了应对这项挑战,医疗产业正在积极调整筹资策略,尽可能地促进本地生产,并呼吁对紧急医疗产品实施关税豁免。

本研究报告是商业研究公司(The Business Research Company)最新系列报告的一部分,该系列报告提供可解释诊断人工智慧(DPAI)市场统计数据,包括全球市场规模、区域份额、竞争对手及其市场份额、详细的DPAI市场细分、市场趋势和商业机会,以及在DPAI行业取得成功所需的数据。本DPAI市场研究报告对该行业的现状和未来发展趋势进行了详细分析,为您提供所需的一切全面观点。

个人化医疗需求的不断增长预计将推动可解释诊断人工智慧(AI)市场的扩张。个人化医疗是指根据个人的基因组成、生活方式和环境来客製化预防、诊断和治疗方案。随着基因组数据和定序技术的不断进步,治疗方案正变得越来越有针对性、更有效,并为每位患者量身定制。可解释诊断人工智慧在其中发挥关键作用,它能够提供清晰、可解释的患者特定数据洞察,从而帮助医生做出更准确的治疗决策。例如,总部位于美国的非营利组织「个人化医疗联盟」(Personalized Medicine Coalition)在2024年2月报告称,美国食品药物管理局(FDA)在2023年核准了16种针对罕见疾病的新型个人化疗法,较2022年的6种显着增加。这些疗法包括抗癌药物和其他疾病的治疗,凸显了人们对个人化医疗日益增长的关注。个人化医疗的蓬勃发展正在推动对可解释诊断人工智慧的需求。

可解释诊断人工智慧市场中的公司正在开发先进的解决方案,例如人工智慧驱动的HER2评分演算法,以提高癌症治疗的诊断准确性和透明度。 HER2评分演算法是一种人工智慧工具,可分析医学影像(例如乳癌组织样本)以评估HER2蛋白的表达量。它们提供准确、一致且易于解释的结果,从而指导诊断和个人化治疗决策。例如,总部位于美国的AI驱动型数位病理诊断公司PathAI于2023年7月推出了AIM-HER2乳癌解决方案,该方案提供自动化且可重复的HER2评分。该系统使用可解释的AI热图来突出显示关键组织特征,从而提高诊断的可靠性和透明度。透过分析整个切片检查切片而无需手动选择区域,该工具简化了病理学家的工作流程,并能处理特别棘手的病例。这项人工智慧解决方案旨在提高HER2评分的准确性和效率,使生物製药研究和临床实验室都能从中受益。

2025年7月,专注于人工智慧驱动的数位病理诊断的德国公司Mindpeak与Techcyte达成合作,旨在提升自动化病理诊断工作流程。透过此次合作,Mindpeak的可解释人工智慧工具将整合到Techcyte的Fusion平台中,从而提高数位病理诊断的准确性、效率和可重复性。此次整合旨在透过在整个医疗保健行业实现可扩展的人工智慧主导工作流程,增强癌症诊断和整体患者照护。总部位于美国的Techcyte提供云端基础的人工智慧主导的数位病理平台,并致力于透过先进技术改善诊断结果。

可解释诊断人工智慧市场包括提供资料标註和准备服务、云端基础的人工智慧诊断服务 (DaaS)、人工智慧驱动的诊断咨询服务、持续模型监控、更新和维护服务以及以患者为中心的可解释性报告服务的实体所获得的收入。市场价值包括服务供应商销售的营业单位包含在其服务产品中的相关产品的价值。可解释诊断人工智慧市场还包括医学影像设备、数位病理扫描仪、分子诊断分析仪和就地检验设备的销售额。该市场的产品价值为“出厂价”,即产品製造商或生产商向其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接向最终客户销售的产品价值。该市场的产品价值也包括产品製造商销售的相关服务的价值。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税,以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球可解释诊断人工智慧:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 终端用户产业分析
  • 全球可解释诊断人工智慧市场:成长率分析
  • 全球可解释诊断人工智慧市场表现:规模与成长,2019-2024年
  • 全球可解释诊断人工智慧市场预测:规模与成长,2024-2029年,2034年预测
  • 全球可解释诊断人工智慧:潜在市场规模 (TAM)

第六章 市场细分

  • 全球可解释诊断人工智慧市场:按组件划分,实际值和预测值,2019-2024年、2024-2029年预测值、2034年预测值
  • 软体
  • 硬体
  • 服务
  • 全球可解释诊断人工智慧市场:依部署模式、效能和预测划分,2019-2024年、2024-2029年预测、2034年预测
  • 本地部署
  • 全球可解释诊断人工智慧市场:按应用、效能和预测划分,2019-2024年、2024-2029年预测、2034年预测
  • 医学影像
  • 病理
  • 基因组学
  • 风险评估
  • 治疗建议
  • 其他用途
  • 全球可解释诊断人工智慧市场:依最终用户划分,实际值及预测值,2019-2024年、2024-2029年预测值、2034年预测值
  • 医院
  • 诊断实验室
  • 研究所
  • 诊所
  • 其他最终用户
  • 全球可解释诊断人工智慧市场:依软体、类型、实际值及预测值细分,2019-2024年、2024-2029年预测值、2034年预测值
  • 机器学习平台
  • 自然语言处理工具
  • 电脑视觉工具
  • 全球可解释诊断人工智慧市场:依硬体、类型、实际值和预测值细分,2019-2024年、2024-2029年预测值、2034年预测值
  • 影像设备
  • 计算设备
  • 感测器和扫描仪
  • 全球可解释诊断人工智慧市场:按服务、类型、实际值和预测值细分,2019-2024年、2024-2029年预测值、2034年预测值
  • 咨询与实施
  • 维护和支援
  • 培训和教育

第七章 区域和国家分析

  • 全球可解释诊断人工智慧市场:按地区、效能和预测划分,2019-2024年、2024-2029年预测、2034年预测
  • 全球可解释诊断人工智慧市场:国家/地区、绩效及预测,2019-2024年、2024-2029年预测、2034年预测

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章:澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章:西欧市场

第十六章英国市场

第十七章:德国市场

第十八章:法国市场

第十九章:义大利市场

第二十章:西班牙市场

第21章 东欧市场

第22章:俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第三十章:竞争格局与公司概况

  • 人工智慧诊断市场概览:竞争格局
  • 诊断人工智慧市场概览:公司简介
    • Fujitsu Limited Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Tempus AI Overview, Products and Services, Strategy and Financial Analysis
    • Owkin Inc. Overview, Products and Services, Strategy and Financial Analysis
    • PathAI Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章:其他领先和创新企业

  • Aidoc Medical Ltd.
  • Viz.ai Inc.
  • Qure.ai Technologies Private Limited
  • Paige.AI Inc.
  • Digital Diagnostics Inc.
  • Enlitic
  • Aignostics GmbH
  • Proscia Inc.
  • Corti ApS
  • Fiddler AI Inc.
  • Riverain Technologies LLC
  • Arthur AI Inc.
  • InData Labs
  • Ibex Medical Analytics Ltd.
  • Mindpeak GmbH

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章:高潜力市场国家、细分市场与策略

  • 2029年诊断人工智慧市场概况:蕴藏新机会的国家
  • 2029年诊断人工智慧市场概况:蕴藏新机会的细分市场
  • 2029年诊断人工智慧市场概览:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38522

Explainable artificial intelligence for diagnostics is the application of AI in healthcare that delivers transparent and interpretable outputs, allowing clinicians and patients to understand how diagnostic decisions are made. Its primary goal is to improve trust, accountability, and accuracy in AI-driven medical assessments by making algorithms understandable.

The primary components of explainable artificial intelligence for diagnostics include software, hardware, and services. Software consists of programs, instructions, or data that operate computers and perform specific tasks. Deployment methods include on-premises and cloud-based solutions. Applications cover medical imaging, pathology, genomics, risk assessment, treatment recommendation, and other areas. Primary end users include hospitals, diagnostic laboratories, research institutes, clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The explainable artificial intelligence for diagnostics market research report is one of a series of new reports from The Business Research Company that provides explainable artificial intelligence for diagnostics market statistics, including explainable artificial intelligence for diagnostics industry global market size, regional shares, competitors with an explainable artificial intelligence for diagnostics market share, detailed explainable artificial intelligence for diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the explainable artificial intelligence for diagnostics industry. This explainable artificial intelligence for diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The explainable artificial intelligence for diagnostics market size has grown exponentially in recent years. It will grow from $1.34 billion in 2024 to $1.69 billion in 2025 at a compound annual growth rate (CAGR) of 26.0%. Growth in the historic period was driven by the increasing prevalence of chronic and lifestyle-related diseases, rising demand for early disease detection, greater patient awareness of personalized care, growing need for accurate and efficient diagnostic solutions, and expanding use of medical imaging and pathology data.

The explainable artificial intelligence for diagnostics market size is expected to see exponential growth in the next few years. It will grow to $4.21 billion in 2029 at a compound annual growth rate (CAGR) of 25.7%. Growth in the forecast period is expected to result from rising demand for explainable and interpretable AI solutions, growing need for personalized medicine, stronger emphasis on predictive analytics, increasing regulatory support for AI-driven diagnostics, and higher demand for transparency in medical decision-making. Primary trends anticipated for the forecast period include advancements in AI algorithms for transparent predictions, integration of AI with medical imaging and genomics, development of cloud-based AI diagnostic platforms, innovations in automated pathology scoring systems, and progress in user-friendly interpretability dashboards.

The growing demand for personalized medicine is expected to fuel the expansion of the explainable artificial intelligence (AI) for diagnostics market. Personalized medicine involves customizing prevention, diagnosis, and treatment based on an individual's genetic makeup, lifestyle, and environment. As advancements in genomic data and sequencing technologies continue, treatments are becoming more targeted, effective, and tailored to individual patients. Explainable AI in diagnostics plays a crucial role in this by offering clear and interpretable insights into patient-specific data, facilitating more precise treatment decisions. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, a significant increase from six in 2022. These treatments included cancer drugs and therapies for other diseases, highlighting the growing focus on personalized care. This surge in personalized medicine is driving demand for explainable AI in diagnostics.

Companies in the explainable AI for diagnostics market are developing advanced solutions, such as AI-driven HER2 scoring algorithms, to improve diagnostic accuracy and transparency in cancer care. The HER2 scoring algorithm is an AI-powered tool that analyzes medical images, such as breast cancer tissue samples, to assess the expression levels of the HER2 protein. It provides accurate, consistent, and interpretable results to guide diagnosis and personalized treatment decisions. For example, in July 2023, PathAI, a U.S.-based AI-powered digital pathology company, launched AIM-HER2 Breast Cancer, which offers automated, reproducible HER2 scoring. This system uses explainable AI heatmaps to highlight key tissue features, enhancing diagnostic confidence and transparency. By analyzing entire biopsy slides without requiring manual region selection, the tool streamlines pathologists' workflows, especially for challenging cases. This AI-powered solution aims to improve accuracy and efficiency in HER2 scoring, benefiting both biopharma research and clinical labs.

In July 2025, Mindpeak GmbH, a German company specializing in AI-powered digital pathology, partnered with Techcyte Inc. to enhance automated pathology workflows. This collaboration integrates Mindpeak's explainable AI tools into Techcyte's Fusion platform, improving diagnostic accuracy, efficiency, and reproducibility in digital pathology. The integration aims to enhance cancer diagnostics and overall patient care by enabling scalable, AI-driven workflows across the healthcare industry. Techcyte, a U.S.-based company, offers a cloud-based AI-driven digital pathology platform that focuses on improving diagnostic results through advanced technology.

Major players in the explainable artificial intelligence for diagnostics market are Fujitsu Limited, Koninklijke Philips N.V., Tempus AI, Owkin Inc., PathAI Inc., Aidoc Medical Ltd., Viz.ai Inc., Qure.ai Technologies Private Limited, Paige.AI Inc., Digital Diagnostics Inc., Enlitic, Aignostics GmbH, Proscia Inc., Corti ApS, Fiddler AI Inc., Riverain Technologies LLC, Arthur AI Inc., InData Labs, Ibex Medical Analytics Ltd., Mindpeak GmbH, and Therapixel SAS.

North America was the largest region in the explainable artificial intelligence for diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in explainable artificial intelligence for diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the explainable artificial intelligence for diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The explainable artificial intelligence for diagnostics market includes revenues earned by entities by providing services such as data annotation and preparation services, cloud-based AI diagnostics-as-a-service (DaaS), AI-powered diagnostic consulting services, ongoing model monitoring, updates, and maintenance services, and patient-centric explainability reporting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The explainable artificial intelligence for diagnostics market also includes sales of medical imaging devices, digital pathology scanners, molecular diagnostic analyzers, and point-of-care testing devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Explainable Artificial Intelligence For Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on explainable artificial intelligence for diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for explainable artificial intelligence for diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The explainable artificial intelligence for diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Deployment Mode: On-Premises; Cloud
  • 3) By Application: Medical Imaging; Pathology; Genomics; Risk Assessment; Treatment Recommendation; Other Applications
  • 4) By End-User: Hospitals; Diagnostic Laboratories; Research Institutes; Clinics; Other End-Users
  • Subsegments:
  • 1) By Software: Machine Learning Platforms; Natural Language Processing Tools; Computer Vision Tools
  • 2) By Hardware: Imaging Devices; Computational Devices; Sensors And Scanners
  • 3) By Services: Consulting And Implementation; Maintenance And Support; Training And Education
  • Companies Mentioned: Fujitsu Limited; Koninklijke Philips N.V.; Tempus AI; Owkin Inc.; PathAI Inc.; Aidoc Medical Ltd.; Viz.ai Inc.; Qure.ai Technologies Private Limited; Paige.AI Inc.; Digital Diagnostics Inc.; Enlitic; Aignostics GmbH; Proscia Inc.; Corti ApS; Fiddler AI Inc.; Riverain Technologies LLC; Arthur AI Inc.; InData Labs; Ibex Medical Analytics Ltd.; Mindpeak GmbH; Therapixel SAS.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Explainable Artificial Intelligence For Diagnostics Market Characteristics

3. Explainable Artificial Intelligence For Diagnostics Market Trends And Strategies

4. Explainable Artificial Intelligence For Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Explainable Artificial Intelligence For Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Explainable Artificial Intelligence For Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Explainable Artificial Intelligence For Diagnostics Market Growth Rate Analysis
  • 5.4. Global Explainable Artificial Intelligence For Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Explainable Artificial Intelligence For Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Explainable Artificial Intelligence For Diagnostics Total Addressable Market (TAM)

6. Explainable Artificial Intelligence For Diagnostics Market Segmentation

  • 6.1. Global Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Hardware
  • Services
  • 6.2. Global Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Premises
  • Cloud
  • 6.3. Global Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medical Imaging
  • Pathology
  • Genomics
  • Risk Assessment
  • Treatment Recommendation
  • Other Applications
  • 6.4. Global Explainable Artificial Intelligence For Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Clinics
  • Other End-Users
  • 6.5. Global Explainable Artificial Intelligence For Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Machine Learning Platforms
  • Natural Language Processing Tools
  • Computer Vision Tools
  • 6.6. Global Explainable Artificial Intelligence For Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Imaging Devices
  • Computational Devices
  • Sensors And Scanners
  • 6.7. Global Explainable Artificial Intelligence For Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting And Implementation
  • Maintenance And Support
  • Training And Education

7. Explainable Artificial Intelligence For Diagnostics Market Regional And Country Analysis

  • 7.1. Global Explainable Artificial Intelligence For Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Explainable Artificial Intelligence For Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Explainable Artificial Intelligence For Diagnostics Market

  • 8.1. Asia-Pacific Explainable Artificial Intelligence For Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Explainable Artificial Intelligence For Diagnostics Market

  • 9.1. China Explainable Artificial Intelligence For Diagnostics Market Overview
  • 9.2. China Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Explainable Artificial Intelligence For Diagnostics Market

  • 10.1. India Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Explainable Artificial Intelligence For Diagnostics Market

  • 11.1. Japan Explainable Artificial Intelligence For Diagnostics Market Overview
  • 11.2. Japan Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Explainable Artificial Intelligence For Diagnostics Market

  • 12.1. Australia Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Explainable Artificial Intelligence For Diagnostics Market

  • 13.1. Indonesia Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Explainable Artificial Intelligence For Diagnostics Market

  • 14.1. South Korea Explainable Artificial Intelligence For Diagnostics Market Overview
  • 14.2. South Korea Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Explainable Artificial Intelligence For Diagnostics Market

  • 15.1. Western Europe Explainable Artificial Intelligence For Diagnostics Market Overview
  • 15.2. Western Europe Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Explainable Artificial Intelligence For Diagnostics Market

  • 16.1. UK Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Explainable Artificial Intelligence For Diagnostics Market

  • 17.1. Germany Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Explainable Artificial Intelligence For Diagnostics Market

  • 18.1. France Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Explainable Artificial Intelligence For Diagnostics Market

  • 19.1. Italy Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Explainable Artificial Intelligence For Diagnostics Market

  • 20.1. Spain Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Explainable Artificial Intelligence For Diagnostics Market

  • 21.1. Eastern Europe Explainable Artificial Intelligence For Diagnostics Market Overview
  • 21.2. Eastern Europe Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Explainable Artificial Intelligence For Diagnostics Market

  • 22.1. Russia Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Explainable Artificial Intelligence For Diagnostics Market

  • 23.1. North America Explainable Artificial Intelligence For Diagnostics Market Overview
  • 23.2. North America Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Explainable Artificial Intelligence For Diagnostics Market

  • 24.1. USA Explainable Artificial Intelligence For Diagnostics Market Overview
  • 24.2. USA Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Explainable Artificial Intelligence For Diagnostics Market

  • 25.1. Canada Explainable Artificial Intelligence For Diagnostics Market Overview
  • 25.2. Canada Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Explainable Artificial Intelligence For Diagnostics Market

  • 26.1. South America Explainable Artificial Intelligence For Diagnostics Market Overview
  • 26.2. South America Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Explainable Artificial Intelligence For Diagnostics Market

  • 27.1. Brazil Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Explainable Artificial Intelligence For Diagnostics Market

  • 28.1. Middle East Explainable Artificial Intelligence For Diagnostics Market Overview
  • 28.2. Middle East Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Explainable Artificial Intelligence For Diagnostics Market

  • 29.1. Africa Explainable Artificial Intelligence For Diagnostics Market Overview
  • 29.2. Africa Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Explainable Artificial Intelligence For Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Explainable Artificial Intelligence For Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Explainable Artificial Intelligence For Diagnostics Market Competitive Landscape
  • 30.2. Explainable Artificial Intelligence For Diagnostics Market Company Profiles
    • 30.2.1. Fujitsu Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Tempus AI Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Owkin Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. PathAI Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Explainable Artificial Intelligence For Diagnostics Market Other Major And Innovative Companies

  • 31.1. Aidoc Medical Ltd.
  • 31.2. Viz.ai Inc.
  • 31.3. Qure.ai Technologies Private Limited
  • 31.4. Paige.AI Inc.
  • 31.5. Digital Diagnostics Inc.
  • 31.6. Enlitic
  • 31.7. Aignostics GmbH
  • 31.8. Proscia Inc.
  • 31.9. Corti ApS
  • 31.10. Fiddler AI Inc.
  • 31.11. Riverain Technologies LLC
  • 31.12. Arthur AI Inc.
  • 31.13. InData Labs
  • 31.14. Ibex Medical Analytics Ltd.
  • 31.15. Mindpeak GmbH

32. Global Explainable Artificial Intelligence For Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Explainable Artificial Intelligence For Diagnostics Market

34. Recent Developments In The Explainable Artificial Intelligence For Diagnostics Market

35. Explainable Artificial Intelligence For Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Explainable Artificial Intelligence For Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Explainable Artificial Intelligence For Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Explainable Artificial Intelligence For Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer